首页 > 市场调查报告书 > 医疗设备

电子医疗设备

深层脑部刺激器市场规模、份额和成长分析（按产品类型、应用、最终用户和地区划分）：产业预测（2026-2033 年）

市场调查报告书

商品编码

1898150

深层脑部刺激器市场规模、份额和成长分析（按产品类型、应用、最终用户和地区划分）：产业预测（2026-2033 年）

Deep Brain Stimulation Devices Market Size, Share, and Growth Analysis, By Product Type (Single-channel DBS Devices, Dual-channel DBS Devices), By Application (Epilepsy, Pain Management), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月17日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球深层脑部刺激器市场规模预计在 2024 年达到 16.8 亿美元，从 2025 年的 18.3 亿美元成长到 2033 年的 37.1 亿美元，在预测期（2026-2033 年）内复合年增长率为 9.2%。

全球深层脑部刺激器市场正经历显着成长，这主要得益于帕金森氏症和自发性震颤等神经系统疾病发病率的上升。这些日益严峻的健康挑战推动了对深部脑部刺激等有效治疗方法的需求。该领域的技术创新，例如可充电设备和精准靶向系统，正在改善治疗效果、安全性和有效性。患者和医疗服务提供者对深部脑部刺激作为一种可行的治疗选择，其显着优势（例如缓解症状和减少药物依赖性）的接受度不断提高，进一步推动了市场扩张。此外，已开发市场和新兴市场有利的报销政策以及不断增长的医疗保健投资，也为製造商提供了有效拓展市场和丰富产品线的良机。

全球深层脑部刺激器市场驱动因素

全球深层脑部刺激器市场的发展动力源自于持续不断的技术创新，这些创新不仅改善了病患的治疗效果，也拓展了可治疗疾病的范围。近期的进展催生了许多先进功能，例如封闭回路型系统和自适应演算法，以及更精确的标靶系统和更精细的刺激参数。这些技术进步使得个人化治疗策略成为可能，从而改善症状控制，提高整体疗效，并最大限度地减少副作用。由此带来的治疗效果和安全性日益提升，也促进了深层脑部刺激器在各个医学领域的广泛应用。

阻碍因素全球深层脑部刺激器市场的因素

全球深层脑部刺激器市场面临诸多限制因素，主要源自于这些设备的复杂性以及手术植入所需的极高精准度。设备相关费用，包括硬体、导线和相关程式系统，可能相当可观。此外，手术本身高成本，需要专用设备、专属手术室资源以及全面的术后照护。这些经济负担阻碍了设备的普及和可近性，尤其是在资源匮乏地区和医疗保险覆盖不足的人群中，限制了深部脑部刺激技术的潜在应用范围和普及程度。

全球深层脑部刺激器市场趋势

全球深部脑部刺激（DBS）设备市场正经历显着成长，主要驱动因素是帕金森氏症、自发性震颤和肌张力不全症等神经系统疾病盛行率的上升。人口老化、慢性病盛行率的快速增长以及环境毒素暴露的增加也是推动这一增长的因素。随着患者和医疗机构越来越多地选择DBS作为一种高效的治疗方案，对DBS设备的需求预计将持续成长。这一趋势凸显了先进医疗技术在应对复杂神经系统疾病挑战方面发挥的关键作用，也使DBS市场成为一个充满创新和投资潜力的领域。

美敦力公司（美国）
雅培实验室（美国）
波士顿科学公司（美国）
Aleva Neurotherapeutics SA（瑞士）
北京平斯医疗有限公司（中国）
Brainsway有限公司（美国）
NeuroPace公司（美国）
功能神经调控有限公司（美国）
NeuroSigma公司（美国）
北京品驰医疗器材有限公司（中国）
SceneRay Corporation Ltd.（中国）
智人引导脑部刺激（荷兰）
雷尼绍有限公司（英国）
Synapse Biomedical Inc.（美国）
Deep Brain Innovations LLC（美国）
Newronika SpA（义大利）
Nexstim Plc（芬兰）
Neuronetics公司（美国）
Magstim有限公司（英国）
Bioinduction Ltd.（英国）

结论与建议

简介目录

Product Code: SQMIG35G2217

Global Deep Brain Stimulation Devices Market size was valued at USD 1.68 Billion in 2024 and is poised to grow from USD 1.83 Billion in 2025 to USD 3.71 Billion by 2033, growing at a CAGR of 9.2% during the forecast period (2026-2033).

The global deep brain stimulation devices market is experiencing significant growth, influenced by the rising incidence of neurological disorders such as Parkinson's disease and essential tremor. This growing health concern has heightened the demand for effective treatments like deep brain stimulation. Technological innovations within the field, including rechargeable devices and enhanced targeting systems, have improved treatment outcomes, safety, and efficacy. Increasing acceptance of deep brain stimulation as a viable therapeutic option among patients and healthcare providers is further driving market expansion, as it offers substantial benefits like symptom relief and reduced medication reliance. Additionally, favorable reimbursement policies and rising healthcare investments in both developed and emerging markets present robust opportunities for manufacturers to broaden their reach and enhance their product offerings effectively.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Deep Brain Stimulation Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Deep Brain Stimulation Devices Market Segments Analysis

Global Deep Brain Stimulation Devices Market is segmented by Product Type, Application, End User and region. Based on Product Type, the market is segmented into Single-channel DBS Devices and Dual-channel DBS Devices. Based on Application, the market is segmented into Epilepsy, Pain Management, Essential Tremor, Obsessive Compulsive Disorder (OCD), Parkinson's Disease, Depression, Dystonia and Others. Based on End User, the market is segmented into Hospitals, Neurology Clinics, Ambulatory Surgical Centers, Research Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Deep Brain Stimulation Devices Market

The Global Deep Brain Stimulation Devices market is propelled by continual innovations in technology that enhance patient outcomes and broaden the spectrum of treatable conditions. Recent advancements have led to the creation of more accurate targeting systems and refined stimulation parameters, in addition to the incorporation of sophisticated features like closed-loop systems and adaptive algorithms. These technological enhancements facilitate personalized treatment strategies, leading to improved symptom management, greater overall efficacy, and minimized side effects. As a result, the therapy is becoming increasingly effective and safe, contributing to the growing adoption of deep brain stimulation devices across various medical disciplines.

Restraints in the Global Deep Brain Stimulation Devices Market

The Global Deep Brain Stimulation Devices market faces significant restraints primarily due to the intricate nature of these devices and the precision required for their surgical implantation. The expenses associated with the devices, which encompass the hardware, leads, and related programming systems, can be considerable. Furthermore, the surgical procedures themselves involve high costs, necessitating specialized equipment, dedicated operating room resources, and comprehensive post-operative care. Such financial burdens create barriers to affordability and accessibility, especially in areas where healthcare resources are scarce or insurance coverage is insufficient, limiting the potential reach and adoption of deep brain stimulation technologies.

Market Trends of the Global Deep Brain Stimulation Devices Market

The Global Deep Brain Stimulation (DBS) Devices market is experiencing significant growth, primarily fueled by the rising prevalence of neurological disorders such as Parkinson's disease, essential tremor, and dystonia. Contributing factors include an aging population, the surge in chronic disease prevalence, and heightened exposure to environmental toxins. As patients and healthcare providers increasingly turn to DBS as a highly effective treatment option, the demand for these devices is expected to expand. This trend underscores the critical role of advanced medical technologies in addressing complex neurological challenges, positioning the DBS market for continued innovation and investment in the foreseeable future.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technology Analysis
Regulatory Analysis

Global Deep Brain Stimulation Devices Market Size by Product Type & CAGR (2026-2033)

Market Overview
Single-channel DBS Devices
Dual-channel DBS Devices

Global Deep Brain Stimulation Devices Market Size by Application & CAGR (2026-2033)

Market Overview
Epilepsy
Pain Management
Essential Tremor
Obsessive Compulsive Disorder (OCD)
Parkinson's Disease
Depression
Dystonia
Others

Global Deep Brain Stimulation Devices Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Neurology Clinics
Ambulatory Surgical Centers
Research Centers
Others

Global Deep Brain Stimulation Devices Market Size & CAGR (2026-2033)

North America (Product Type, Application, End User)
- US
- Canada
Europe (Product Type, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Medtronic Plc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aleva Neurotherapeutics S.A. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beijing PINS Medical Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Brainsway Ltd. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NeuroPace Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Functional Neuromodulation Ltd. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NeuroSigma, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beijing Pinchi Medical Equipment Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SceneRay Corporation Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sapiens Steering Brain Stimulation (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Renishaw plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synapse Biomedical Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Deep Brain Innovations LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Newronika S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nexstim Plc (Finland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neuronetics, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Magstim Company Limited (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioinduction Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments